Characterization of Pancreatic Adenocarcinoma Patients Using NGS
Demographics (2)
- AGE - Age at expiration (phv00179508.v1.p1)
- SEX - Gender of participant (phv00179509.v1.p1)
Race and Ethnicity (1)
- RACE - Race of participant (phv00179510.v1.p1)
Other (16)
- ANALYTE_TYPE - Analyte Type (phv00179514.v1.p1)
- BODY_SITE - Body site where sample was collected (phv00179513.v1.p1)
- CONSENT - Consent given by subject for sample collection (phv00179502.v1.p1)
- IS_TUMOR - Tumor status (phv00179515.v1.p1)
- PRIMARY_METASTATIC_TUMOR - Primary tumor, metastasis, or transformed cell line (phv00179516.v1.p1)
- PRIMARY_TUMOR_LOCATION - Primary tumor location (phv00179517.v1.p1)
- RESEARCH_TYPE - Type of research subject data was used for (phv00179503.v1.p1)
- SAMPID - De-identified sample ID (phv00179512.v1.p1)
- SAMPID - Sample ID (phv00179505.v1.p1)
- SAMPLE_USE - Sample use (phv00179506.v1.p1)
- STATUS - Current status of subject (phv00179511.v1.p1)
- SUBJID - De-identified subject ID (phv00179507.v1.p1)
- SUBJID - Subject ID (phv00179501.v1.p1)
- SUBJID - Subject ID (phv00179504.v1.p1)
- TUMOR_STAGE - Tumor stage of sample (phv00179518.v1.p1)
- TUMOR_TREATMENT - Type of tumor treatment for sample (phv00179519.v1.p1)